Convertibles Calendar: Molycorp, Integra LifeSciences to price deals

JUNE 9

MOLYCORP INC. (NYSE: MCP): $200 million of five-year convertible senior notes; pricing Thursday after the market close; price talk revised to 3%-3.5%, up 37.5%-40%, from original talk of 3.25%-3.75%, up 27.5%-32.5%; Rule 144A; $30 million greenshoe; concurrent registered offering of 10 million shares of common stock; both deals via J.P. Morgan Securities LLC and Morgan Stanley & Co. Inc.; non-callable; no puts; takeover and dividend protection; proceeds for production capacity and expansion plan at its Mountain Pass, Calif., processing facility and for general corporate purposes; Greenwood Village, Colo.-based producer of rare earth oxides.

INTEGRA LIFESCIENCES HOLDINGS CORP. (Nasdaq: IART): $200 million of five-year convertible senior; pricing late Thursday; Rule 144A deal; talked at a 1.25%-1.75%, up 22.5%-27.5%; $30 million greenshoe; via joint bookrunners J.P. Morgan Securities LLC, Morgan Stanley & Co. Inc., Bank of America Merrill Lynch, Deutsche Bank Securities Inc., Wells Fargo Securities LLC and RBC Capital Markets LLC; concurrent convertible note hedge transactions; proceeds for at least $40 million of common share purchases, to repay some of Integra's senior credit facility and for general corporate purposes; Plainsboro, N.J.-based maker and marketer of surgical implants and medical instruments for neurosurgery, extremity reconstruction and orthopedics.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.